ASCLETIS-B (01672) spend approximately HK$970,000 to repurchase 100,000 shares on October 27th.
Gale Pharmaceutical Group-B (01672) announced that the company will invest approximately HK$970,000 on October 27, 2025...
ASCLETIS-B (01672) announced on October 27, 2025 that the company will spend approximately 970,000 Hong Kong dollars to repurchase 100,000 shares. The repurchase price is between 9.58 and 9.73 Hong Kong dollars per share.
Related Articles
Huaxin Cement (06655) has repurchased 2.578 million A-shares in actuality.
Holodotus (HOLO.US) is expected to have a net profit exceeding 3.5 billion yuan for the entire year and plans to invest 400 million dollars in cutting edge areas such as quantum computing.
Microsoft Corporation (MSFT.US) ratings have been raised by Guggenheim. Wall Street overwhelmingly recommends "buy".
Huaxin Cement (06655) has repurchased 2.578 million A-shares in actuality.
Holodotus (HOLO.US) is expected to have a net profit exceeding 3.5 billion yuan for the entire year and plans to invest 400 million dollars in cutting edge areas such as quantum computing.
Microsoft Corporation (MSFT.US) ratings have been raised by Guggenheim. Wall Street overwhelmingly recommends "buy".
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
